Payment overview · 2025
General Payments
$19.73
1 reported records · 1 companies
Healthcare provider profile · identity verified
Dejun Wang, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · ROWLAND HEIGHTS, CA · NPI 1275559288
Verified facts
What the public records show
CMS Open Payments records show Dejun Wang, M.D. received $19.73 in general payments during 2025 across 1 reported records.
E.R. Squibb & Sons, L.L.C. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 139 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $19.73 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.73 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| COBENFY Normalized: cobenfy |
Drug | E.R. Squibb & Sons, L.L.C. | $19.73 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
139 | 25 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1296 | 347 |
| Amlodipine Besylate | Amlodipine Besylate | 1079 | 265 |
| Losartan Potassium | Losartan Potassium | 833 | 212 |
| Metformin Hcl | Metformin Hcl | 648 | 164 |
| Zolpidem Tartrate | Zolpidem Tartrate | 509 | 173 |
| Metoprolol Succinate | Metoprolol Succinate | 467 | 117 |
| Levothyroxine Sodium | Levothyroxine Sodium | 403 | 95 |
| Alendronate Sodium | Alendronate Sodium | 402 | 114 |
| Omeprazole | Omeprazole | 394 | 144 |
| Tamsulosin Hcl | Tamsulosin Hcl | 387 | 116 |
| Azithromycin | Azithromycin | 358 | 243 |
| Jardiance | Empagliflozin | 327 | 55 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 273 | 76 |
| Celecoxib | Celecoxib | 262 | 75 |
| Vascepa | Icosapent Ethyl | 261 | 65 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 254 | 67 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 240 | 119 |
| Clopidogrel | Clopidogrel Bisulfate | 236 | 67 |
| Donepezil Hcl | Donepezil Hcl | 229 | 54 |
| Finasteride | Finasteride | 228 | 66 |
| Pantoprazole Sodium | Pantoprazole Sodium | 224 | 65 |
| Azelastine Hcl | Azelastine Hcl | 214 | 79 |
| Farxiga | Dapagliflozin Propanediol | 210 | 42 |
| Glimepiride | Glimepiride | 195 | 45 |
| Allopurinol | Allopurinol | 191 | 41 |
| Meloxicam | Meloxicam | 191 | 71 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 191 | 102 |
| Simvastatin | Simvastatin | 189 | 46 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 177 | 32 |
| Linzess | Linaclotide | 168 | 40 |
| Dexlansoprazole Dr | Dexlansoprazole | 157 | 36 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 149 | 34 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 146 | 59 |
| Gabapentin | Gabapentin | 145 | 56 |
| Ezetimibe | Ezetimibe | 142 | 33 |
| Eliquis | Apixaban | 139 | 25 |
| Sucralfate | Sucralfate | 136 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 126 | 41 |
| Cyclosporine | Cyclosporine | 123 | 47 |
| Dutasteride | Dutasteride | 123 | 26 |
| Famotidine | Famotidine | 123 | 40 |
| Icosapent Ethyl | Icosapent Ethyl | 123 | 44 |
| Xarelto | Rivaroxaban | 122 | 21 |
| Carvedilol | Carvedilol | 121 | 25 |
| Nitroglycerin | Nitroglycerin | 114 | 52 |
| Fluocinonide | Fluocinonide | 112 | 60 |
| Lisinopril | Lisinopril | 102 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 102 | 28 |
| Furosemide | Furosemide | 99 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 98 | 29 |
| Amoxicillin | Amoxicillin | 97 | 66 |
| Raloxifene Hcl | Raloxifene Hcl | 97 | 18 |
| Ciclopirox | Ciclopirox Olamine | 95 | 39 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 91 | 26 |
| Januvia | Sitagliptin Phosphate | 90 | 20 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 88 | 77 |
| Evenity (2 Syringes) | Romosozumab-Aqqg | 78 | 11 |
| Potassium Chloride | Potassium Chloride | 78 | 23 |
| Benazepril Hcl | Benazepril Hcl | 76 | 18 |
| Glipizide | Glipizide | 76 | 20 |
| Diclofenac Sodium | Diclofenac Sodium | 75 | 51 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 75 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 75 | 15 |
| Restasis | Cyclosporine | 73 | 25 |
| Sertraline Hcl | Sertraline Hcl | 72 | 16 |
| Montelukast Sodium | Montelukast Sodium | 71 | 19 |
| Doxepin Hcl | Doxepin Hcl | 70 | 30 |
| Lidocaine | Lidocaine | 70 | 14 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 69 | 27 |
| Creon | Lipase/Protease/Amylase | 64 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 63 | 15 |
| Hydralazine Hcl | Hydralazine Hcl | 61 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 60 | 11 |
| Prolia | Denosumab | 60 | 38 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 59 | 22 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 58 | 13 |
| Valsartan | Valsartan | 58 | suppressed |
| Hydrocortisone | Hydrocortisone | 57 | 27 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 56 | 20 |
| Glipizide Er | Glipizide | 55 | 14 |
| Terazosin Hcl | Terazosin Hcl | 54 | 12 |
| Atenolol | Atenolol | 53 | 13 |
| Nebivolol Hcl | Nebivolol Hcl | 53 | 15 |
| Hydrochlorothiazide | Hydrochlorothiazide | 52 | 12 |
| Meclizine Hcl | Meclizine Hcl | 52 | 32 |
| Colchicine | Colchicine | 50 | 20 |
| Ibuprofen | Ibuprofen | 50 | 39 |
| Alprazolam | Alprazolam | 49 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 49 | suppressed |
| Irbesartan | Irbesartan | 49 | 13 |
| Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate | 47 | 11 |
| Temazepam | Temazepam | 46 | suppressed |
| Vemlidy | Tenofovir Alafenamide | 45 | suppressed |
| Ranolazine Er | Ranolazine | 44 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | 15 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 42 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 41 | suppressed |
| Prednisone | Prednisone | 41 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 39 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 39 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 39 | 15 |
| Memantine Hcl Er | Memantine Hcl | 37 | 11 |
| Multaq | Dronedarone Hcl | 37 | suppressed |
| Myrbetriq | Mirabegron | 37 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 37 | suppressed |
| Acarbose | Acarbose | 36 | 13 |
| Lorazepam | Lorazepam | 36 | 17 |
| Memantine Hcl | Memantine Hcl | 36 | suppressed |
| Spironolactone | Spironolactone | 36 | suppressed |
| Tradjenta | Linagliptin | 36 | suppressed |
| Clonazepam | Clonazepam | 35 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 35 | 12 |
| Gemtesa | Vibegron | 34 | 12 |
| Mirtazapine | Mirtazapine | 34 | suppressed |
| Proctozone-Hc | Hydrocortisone | 34 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 21 |
| Procto-Med Hc | Hydrocortisone | 33 | 20 |
| Metformin Hcl Er | Metformin Hcl | 32 | 11 |
| Rivastigmine | Rivastigmine | 32 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 31 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 31 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 30 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 30 | 15 |
| Pregabalin | Pregabalin | 30 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 30 | 12 |
| Kerendia | Finerenone | 29 | suppressed |
| Ketoconazole | Ketoconazole | 29 | 18 |
| Zenpep | Lipase/Protease/Amylase | 28 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 27 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 27 | 22 |
| Gemfibrozil | Gemfibrozil | 27 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 27 | 13 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 26 | suppressed |
| Erythromycin | Erythromycin Base | 26 | 13 |
| Tramadol Hcl | Tramadol Hcl | 26 | 11 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 26 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 25 | 14 |
| Mupirocin | Mupirocin | 25 | 16 |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 25 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 25 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 24 | suppressed |
| Baclofen | Baclofen | 24 | 19 |
| Exelon | Rivastigmine | 24 | suppressed |
| Febuxostat | Febuxostat | 24 | suppressed |
| Methylprednisolone | Methylprednisolone | 24 | 22 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 23 | 15 |
| Nifedipine Er | Nifedipine | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 21 |
| Sotalol | Sotalol Hcl | 23 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 23 | suppressed |
| Digoxin | Digoxin | 21 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 21 | 16 |
| Dutasteride-Tamsulosin | Dutasteride/Tamsulosin Hcl | 21 | suppressed |
| Entresto | Sacubitril/Valsartan | 21 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 21 | suppressed |
| Methotrexate | Methotrexate Sodium | 21 | suppressed |
| Telmisartan | Telmisartan | 21 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 20 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 20 | 17 |
| Diltiazem Hcl | Diltiazem Hcl | 20 | suppressed |
| Diphenhydramine Hcl | Diphenhydramine Hcl | 20 | 18 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 20 | suppressed |
| Levofloxacin | Levofloxacin | 20 | 17 |
| Methimazole | Methimazole | 20 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 20 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 20 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 19 | suppressed |
| Lansoprazole | Lansoprazole | 19 | suppressed |
| Naproxen | Naproxen | 19 | 16 |
| Single Use Swab | Alcohol Antiseptic Pads | 19 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 18 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 18 | suppressed |
| Latanoprost | Latanoprost | 18 | suppressed |
| Levetiracetam | Levetiracetam | 18 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 17 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 17 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Loperamide | Loperamide Hcl | 16 | 11 |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 15 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 14 | 14 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Ciclopirox | Ciclopirox | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 13 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Ozempic | Semaglutide | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 13 | suppressed |
| Invokana | Canagliflozin | 12 | suppressed |
| Novofine 32 | Pen Needle, Diabetic | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.73 · 1 records | E.R. Squibb & Sons, L.L.C. | COBENFY | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with E.R. Squibb & Sons, L.L.C.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error